On May 16, 2025, the Department of Biotechnology (DBT) and BIRAC hosted the 14th BioE3 webinar, focusing on "Biomanufacturing for mRNA Therapeutics." This session, part of India's BioE3 Policy, emphasized the nation's commitment to advancing mRNA-based therapies for diseases like cancer and infectious ailments. Experts highlighted India's active role in developing mRNA vaccines and therapeutics, while also addressing challenges such as delivery mechanisms, product stability, and dependence on imported raw materials. The webinar underscored the need for innovation, infrastructure development, and investment to bolster India's position in the global bioeconomy.

Contact: Department of Biotechnology (DBT), Government of India

Website: https://dbtindia.gov.in/

Tel: 011-24362950